Search Results - "DEBINSKI, W"
-
1
Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor
Published in Oncogene (11-12-2008)“…The ephrinA1 ligand exerts antioncogenic effects in tumor cells through activation and downregulation of the EphA2 receptor and has been described as a…”
Get full text
Journal Article -
2
Characterization of Ablation Thresholds for 3D-Cultured Patient-Derived Glioma Stem Cells in Response to High-Frequency Irreversible Electroporation
Published in Research (Washington) (01-01-2019)“…High-frequency irreversible electroporation (H-FIRE) is a technique that uses pulsed electric fields that have been shown to ablate malignant cells. In order…”
Get full text
Journal Article -
3
Hybrid mathematical model of glioma progression
Published in Cell proliferation (01-10-2009)“…Objectives: Gliomas are an important form of brain cancer, with high mortality rate. Mathematical models are often used to understand and predict their…”
Get full text
Journal Article -
4
Genomic Predictors of Imaging Response and Survival in Glioblastoma
Published in International journal of radiation oncology, biology, physics (01-10-2016)Get full text
Journal Article -
5
-
6
Does Delay of Start of Radiation Affect Clinical Outcomes of Glioblastoma
Published in International journal of radiation oncology, biology, physics (01-09-2014)Get full text
Journal Article -
7
FUNCTIONAL PRESENCE OF M2 MACROPHAGE MARKERS IN GBM TUMOR CELLS
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2014)“…BACKGROUND: Tumor associated macrophages (TAMS) have been suggested to be key players in the tumor microenvironment. The M2 activation phenotype is believed to…”
Get full text
Journal Article -
8
Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen
Published in Molecular medicine (Cambridge, Mass.) (01-05-2000)“…The vast majority of patients with high-grade gliomas (HGG) over-express interleukin 4 (IL4)-independent binding sites for IL13 in situ. In addition, mutated…”
Get full text
Journal Article -
9
Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15
Published in The Journal of biological chemistry (14-04-1995)“…Interleukin 13 (IL-13) shares many biological properties with IL-4, and although the receptor for IL-4 (IL-4R) has been characterized, the expression and…”
Get full text
Journal Article -
10
Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin
Published in Clinical cancer research (01-11-1995)“…Recently, we have demonstrated that a spectrum of human adenocarcinoma cell lines express binding sites for interleukin 13 (IL-13). These cells are killed by a…”
Get full text
Journal Article -
11
P06.02 A multivalent protein for immune checkpoint inhibition at the tumor site
Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)“…Monoclonal antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4, CTLA-4 on T cells have demonstrated efficacy in…”
Get full text
Journal Article -
12
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme
Published in Molecular medicine (Cambridge, Mass.) (01-09-2001)“…Glioblastoma multiforme (GBM) is a hypervascularized and locally infiltrating brain tumor of astroglial origin with a very poor prognosis. An X-linked c-fos…”
Get full text
Journal Article -
13
Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain
Published in Journal of neurochemistry (01-02-1999)“…: Studies on iron uptake into the brain have traditionally focused on transport by transferrin. However, transferrin receptors are not found in all brain…”
Get full text
Journal Article -
14
Expression of a restrictive receptor for interleukin 13 is associated with glial transformation
Published in Journal of neuro-oncology (01-06-2000)“…We have previously documented that the vast majority of high-grade gliomas over-express binding sites for interleukin 13 (IL13) in situ. We now extend this…”
Get full text
Journal Article -
15
Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme
Published in International journal of oncology (01-09-1999)“…We have recently documented that the vast majority of patients with glioblastoma multiforme (GBM) over-express a receptor (R) for interleukin 13 (IL13) in…”
Get more information
Journal Article -
16
Targeting of Interleukin-13 Receptor on Human Renal Cell Carcinoma Cells by a Recombinant Chimeric Protein Composed of Interleukin-13 and a Truncated Form of Pseudomonas Exotoxin A (PE38QQR)
Published in Blood (15-05-1996)“…We have previously shown that human renal cell carcinoma (RCC) cells express large numbers of interleukin-13 receptors (IL-13R), a newly described hemopoietic…”
Get full text
Journal Article -
17
Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein
Published in Clinical cancer research (01-02-1997)“…AIDS-associated Kaposi's sarcoma (AIDS-KS), the most common malignant complication of human immunodeficiency virus infection, is characterized by neoplastic…”
Get full text
Journal Article -
18
Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain
Published in Clinical cancer research (01-10-1996)“…Interleukin-13 (IL-13) is a cytokine produced primarily by activated T lymphocytes. It exerts a variety of effects on different cell types, including…”
Get full text
Journal Article -
19
A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin
Published in The Journal of biological chemistry (05-07-1993)“…A chimeric toxin has been constructed by fusion of a gene encoding human interleukin 4 (hIL4) to a gene encoding a mutant form of Pseudomonas exotoxin A (PE)…”
Get full text
Journal Article -
20